Publication:
Tumor Metabolome: Therapeutic Opportunities Targeting Cancer Metabolic Reprogramming

Simple item page
dc.contributor.authorMárquez, Javier
dc.contributor.authorMatés, José M.
dc.contributor.authoraffiliation[Márquez,J; Matés,JM] Departamento de Biología Molecular y Bioquímica, Canceromics Lab, Universidad de Málaga,Málaga, Spain. [Márquez,J; Matés,JM] Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain
dc.date.accessioned2024-02-19T15:24:47Z
dc.date.available2024-02-19T15:24:47Z
dc.date.issued2021-01-16
dc.description.sponsorshipThis work was financially supported by Ministerio de Ciencia y Tecnología of Spain, RTI2018-096866-B-I00 (to J.M. and J.M.M.).
dc.identifier.doi10.3390/cancers13020314
dc.identifier.e-issn2072-6694es_ES
dc.identifier.journalCancerses_ES
dc.identifier.otherhttp://hdl.handle.net/10668/4123
dc.identifier.pubmedID33467031es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/18235
dc.language.isoeng
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI)
dc.relation.publisherversionhttps://www.mdpi.com/2072-6694/13/2/314/htmes
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectIsoenzymes
dc.subjectBreast cancer
dc.subjectGlutaminase
dc.subjectDrug resistance
dc.subjectCell Proliferation
dc.subjectIsoenzimas
dc.subjectNeoplasias de la mama
dc.subjectGlutaminasa
dc.subjectResistencia a medicamentos
dc.subjectProliferación celular
dc.subject.meshHumans
dc.subject.meshGlutaminase
dc.subject.meshGlutaminase
dc.subject.meshEpithelial-Mesenchymal Transition
dc.subject.meshIsoenzymes
dc.subject.meshProteomics
dc.subject.meshTriple Negative Breast Neoplasms
dc.subject.meshCell Proliferation
dc.subject.meshTranscription Factors
dc.subject.meshAmino Acids, Essential
dc.subject.meshGene Expression
dc.subject.meshDrug Resistance
dc.subject.meshEnergy Metabolism
dc.subject.meshDrug Design
dc.subject.meshMetabolome
dc.subject.meshPhenotype
dc.titleTumor Metabolome: Therapeutic Opportunities Targeting Cancer Metabolic Reprogramming
dc.typeeditorial
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isPublisherOfPublication30293a55-0e53-431f-ae8c-14ab01127be9
relation.isPublisherOfPublication.latestForDiscovery30293a55-0e53-431f-ae8c-14ab01127be9

Files

Collections

IBIMA-Plataforma BIONAND - Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (Andalucía)